November 11, 2014


Greg Millet
Six Myths Slowing the Prophylactic Use of... 

Biomedical strategies such as pre-exposure prophylaxis (PrEP) and ARV treatment as prevention are essential to bringing an end to the HIV|more 

 
   
   
  
Providing answers

Marketplace   

Drug pricing

ACA Resources
PrEPline Provides Clinicians...   
A new telephone consultation service was launched earlier this month to provide free, expert advice to clinicians across the United States about|more 

5 Steps to Stay Covered Through the... 
Did you know that if you bought a health insurance plan through the Health Insurance Marketplace in 2014, you can renew your current plan or enroll in a|more 
 

Got Insurance? You Still May Pay A Steep... 

Sandra Grooms recently got a call from her oncologist's office. The chemotherapy drugs he wanted to use on her metastatic breast cancer were covered by|more 
 
 

Upcoming ACE TA Center Webinars to...
Join the ACE TA Center to find out why your enrolled clients should log into the health insurance Marketplace and learn about culturally competent|more     

 



WHAT WE'RE READING

 

A cross-section of articles we've read this week about HIV/AIDS, STIs and a wide cross-section of structural and systemic factors impacting HIV/AIDS in Black communities.

 

 Prevention

 

A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection via anal sex. This finding helps explain why two large clinical trials testing HIV pre-exposure prophylaxis, or PrEP, in women failed to show efficacy. Participants in the VOICE and FEM-PrEP trials of Truvada and tenofovir (another antiretroviral) for HIV prevention were counseled to take one of the medications daily. However, because they actually took the antiretroviral only about 29 percent of the time in VOICE and about 36 percent of the time in FEM-PrEP, the PrEP strategy did not work.

Science

The first structure of the immature form of HIV at a high enough resolution has been obtained by researchers, allowing them to pinpoint exactly where each building block sits in the virus. The study reveals that the building blocks of the immature form of HIV are arranged in a surprising way.

French scientists on Tuesday unveiled the genetic mechanism by which they believe two men were spontaneously cured of HIV, and said the discovery may offer a new strategy in the fight against AIDS.

Scientists have developed a novel topical microbicide loaded with hyaluronic acid (HA) nanofibers that could potentially prevent transmission of the human immunodeficiency virus (HIV) through the vaginal mucosa. This research is being presented at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Diego, Nov. 2-6.

Treatment

A new research examining the effectiveness of current HCV therapies revealed HIV patients coinfected with certain genotypes of Hepatitis C are harder to treat, a report on health news site Healio.com said.

Miscellaneous


In addition to providing other potential benefits to public health, all of those tweets and Facebook posts could help curb the spread of HIV. Although public health researchers have focused early applications of social media on reliably monitoring the spread of diseases such as the flu, a new article tells of a future in which social media might predict and even change biomedical outcomes.

As the world focuses on Ebola, we must not forget that HIV/AIDS presents a far greater challenge in the world of vaccines.

President Barack Obama said he is eager to work with the new Congress to make the next few years as productive as possible, but he said he expects them to disagree on some key issues.

Here in the U.S., AIDS can feel like yesterday's news, and many funders long ago moved on to other issues, including many LGBT funders who've been focused on rights issues.

In This Issue
Phill Wilson
We are just 4 days away from the beginning of Open Enrollment for the Health Insurance Marketplaces and 34 days away from the date enrollment closes for coverage that begins on January 1, 2015.|more 
 

EVENTS 

 

Health Insurance Marketplace Open Enrollment Key Dates:

 

11/15/14 - Open Enrollment begins

 

12/15/14 - Enroll by the 15th for new coverage that begins by Jan. 1, 2015

 

12/31/14 - Coverage ends for 2014 plans. Coverage for 2015 plans can start as soon as Jan 1, 2015.   

 

2/15/15 - Last day you can apply for 2015 coverage before the end of Open Enrollment   

 

Visit healthcare.gov for more infomation 

  

For more information on these events 

contact Rebekah

Isreal at

rebekahi@BlackAIDS.org

or visit 
 
BLACK AIDS
WEEKLY

PHILL WILSON 

Publisher

 

HILARY BEARD 

Editor-in-Chief

 

TERESA RIDLEY 

Copy Editor

 

LASHIEKA P. HUNTER 

Media and Public Relations Consultant


Founded in May of 1999, the Black AIDS Institute is the only national HIV/AIDS think tank focused exclusively on Black people. The Institute's Mission is to stop the AIDS pandemic in Black communities by engaging and mobilizing Black institutions and individuals in efforts to confront HIV. The Institute interprets public and private sector HIV policies, conducts trainings, offers technical assistance, disseminates information and provides advocacy mobilization from a uniquely and unapologetically Black point of view.

Support the Black Aids Institute through the Combined Federal Campaign (CFC# 12320). The Institute holds the Independent Charities Seal of Excellence for meeting the highest standards of public accountability.